Tabula Rasa HealthCare, Inc. Common Stock
TRHC
TRHC was delisted on the 2nd of November, 2023.
96 hedge funds and large institutions have $41.9M invested in Tabula Rasa HealthCare, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 52 reducing their positions, and 51 closing their positions.
8% more call options, than puts
Call options by funds: $281K | Put options by funds: $261K
31% less funds holding
Funds holding: 139 → 96 (-43)
54% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 52
58% less capital invested
Capital invested by funds: $98.7M → $41.9M (-$56.8M)
78% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Indaba Capital Management
San Francisco,
California
|
+$19.4M |
| 2 |
RP
Repertoire Partners
New York
|
+$4.01M |
| 3 |
D.E. Shaw & Co
New York
|
+$807K |
| 4 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
+$750K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$649K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$6.46M |
| 2 |
BlackRock
New York
|
-$4.38M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.76M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.33M |
| 5 |
EGM
Engineers Gate Manager
New York
|
-$1.8M |
TRHC Hedge Fund Activity: Q2 2022 in Review
96 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Tabula Rasa HealthCare, Inc. Common Stock (TRHC) for Q2 2022, worth a combined $41.9M — down 58% from $98.7M a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of TRHC and 11 opened new positions — a net loss of 40 holders — while 52 trimmed existing stakes and 24 added.
The largest buyer was Indaba Capital Management, opening a new position worth an estimated $19.4M. The largest seller was Fred Alger Management, exiting entirely with an estimated $6.46M sold.
- 96 institutional investors held Tabula Rasa HealthCare, Inc. Common Stock (TRHC) as of Q2 2022, down from 139 in Q1 2022.
- Funds reported $41.9M of Tabula Rasa HealthCare, Inc. Common Stock stock for Q2 2022, down 58% quarter-over-quarter.
- 11 funds opened new Tabula Rasa HealthCare, Inc. Common Stock positions in Q2 2022 and 51 closed out, a net change of -40 holders.
- The largest Tabula Rasa HealthCare, Inc. Common Stock buyer in Q2 2022 was Indaba Capital Management, an estimated $19.4M added.
- The largest Tabula Rasa HealthCare, Inc. Common Stock seller in Q2 2022 was Fred Alger Management, an estimated $6.46M sold.
Based on aggregated 13F filings for Q2 2022.